200 related articles for article (PubMed ID: 16297671)
1. Reflux rising! An essay on witnessing a disease in evolution.
Bardhan KD; Royston C; Nayyar AK
Dig Liver Dis; 2006 Mar; 38(3):163-8. PubMed ID: 16297671
[TBL] [Abstract][Full Text] [Related]
2. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea.
Kim N; Lee SW; Cho SI; Park CG; Yang CH; Kim HS; Rew JS; Moon JS; Kim S; Park SH; Jung HC; Chung IS;
Aliment Pharmacol Ther; 2008 Jan; 27(2):173-85. PubMed ID: 17973646
[TBL] [Abstract][Full Text] [Related]
5. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
Pace F; Bollani S; Molteni P; Bianchi Porro G
Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
[TBL] [Abstract][Full Text] [Related]
7. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
Bretagne JF; Rey JF; Caekaert A; Barthélemy P
Dig Liver Dis; 2005 Aug; 37(8):566-70. PubMed ID: 15886080
[TBL] [Abstract][Full Text] [Related]
8. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis.
McDougall NI; Johnston BT; Collins JS; McFarland RJ; Love AH
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1161-7. PubMed ID: 9471021
[TBL] [Abstract][Full Text] [Related]
9. Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis.
Nakamura T; Shirakawa K; Masuyama H; Sugaya H; Hiraishi H; Terano A
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():19-26. PubMed ID: 15943842
[TBL] [Abstract][Full Text] [Related]
10. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of oesophagitis in patients with persistent upper respiratory symptoms.
Catalano F; Terminella C; Grillo C; Biondi S; Zappalà M; Bentivegna C
J Laryngol Otol; 2004 Nov; 118(11):857-61. PubMed ID: 15638971
[TBL] [Abstract][Full Text] [Related]
12. Impact of referral for gastro-oesophageal reflux disease on the workload of an academic Gastroenterology Unit.
Cantù P; Savojardo D; Carmagnola S; Penagini R
Dig Liver Dis; 2005 Oct; 37(10):735-40. PubMed ID: 16024304
[TBL] [Abstract][Full Text] [Related]
13. Carditis: all Helicobacter pylori or is there a role for gastro-oesophageal reflux?
McNamara D; Buckley M; Crotty P; Hall W; O'Sullivan M; O'Morain C
Scand J Gastroenterol; 2002 Jul; 37(7):772-7. PubMed ID: 12190089
[TBL] [Abstract][Full Text] [Related]
14. Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease.
Caviglia R; Ribolsi M; Gentile M; Rabitti C; Emerenziani S; Guarino MP; Petitti T; Cicala M
Aliment Pharmacol Ther; 2007 Mar; 25(5):629-36. PubMed ID: 17305764
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients.
Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):499-506. PubMed ID: 17489061
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for gastro-oesophageal reflux disease symptoms: a community study.
Mohammed I; Nightingale P; Trudgill NJ
Aliment Pharmacol Ther; 2005 Apr; 21(7):821-7. PubMed ID: 15801917
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of gastro-oesophageal reflux disease in general practice].
Hollenz M; Stolte M; Labenz J
Dtsch Med Wochenschr; 2002 May; 127(19):1007-12. PubMed ID: 11997867
[TBL] [Abstract][Full Text] [Related]
18. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
Vakil N; Talley NJ; Stolte M; Sundin M; Junghard O; Bolling-Sternevald E
Aliment Pharmacol Ther; 2006 Jul; 24(1):55-63. PubMed ID: 16803603
[TBL] [Abstract][Full Text] [Related]
19. Review article: Gastro-oesophageal reflux disease--application of the concept of complete remission.
Oudkerk Pool M
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():13-6. PubMed ID: 18081644
[TBL] [Abstract][Full Text] [Related]
20. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
Bautista J; Fullerton H; Briseno M; Cui H; Fass R
Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
